ICRA also have revised the short term credit rating of Bal Pharma to A3+ (Pronounced A three plus) from A 3 ( pronounced as A three) assigned for last financial year 2014.15.

The up gradation of crediting rating of the Company is the indication of its significant improvement in the financial profile by expanding its margins and improvised cash flows.